Literature DB >> 16936751

RB family members as predictive and prognostic factors in human cancer.

G Scambia1, S Lovergine, V Masciullo.   

Abstract

The retinoblastoma family members--pRb, pRb2/p130 and p107--are tumor suppressor genes involved in controlling four major cellular processes: growth arrest, apoptosis, differentiation and angiogenesis. Molecular genetic studies have identified abnormalities of these tumor suppressor genes in a large proportion of human cancers. These genetic alterations have emerged as significant factors in the pathogenesis and progression of many types of tumors and are therefore likely to provide relevant information to assess risk in cancer patients. There is a pressing clinical need to identify prognostic and predictive factors for patients with cancer, because there is an undeniable importance in being able to determine which patients will have a favorable outcome without further therapy (prognostic factor) and which will need some additional treatment (predictive factor). This review examines the predictive and/or prognostic role of each retinoblastoma family member in human cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936751     DOI: 10.1038/sj.onc.1209620

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Screening genes related to development and injury of the mouse optic nerve by cDNA microarrays.

Authors:  Yunlai Liu; Minghui Huang; Yanqi Zhang; Hongli Li; Lan Xiao; Jianjun Liu; Bibo Yuan; Maolin Qin; Chengren Li; Micheal Yang; Wenqin Cai
Journal:  Cell Mol Neurobiol       Date:  2010-03-25       Impact factor: 5.046

Review 2.  E2F1: a promising regulator in ovarian carcinoma.

Authors:  Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Bing Wei
Journal:  Tumour Biol       Date:  2016-01-09

Review 3.  Role of DMP1 and its future in lung cancer diagnostics.

Authors:  Takayuki Sugiyama; Donna P Frazier; Pankaj Taneja; Rachel L Morgan; Mark C Willingham; Kazushi Inoue
Journal:  Expert Rev Mol Diagn       Date:  2008-07       Impact factor: 5.225

4.  Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors.

Authors:  Bu-Nam Jeon; Jung-Yoon Yoo; Won-Il Choi; Choong-Eun Lee; Ho-Geun Yoon; Man-Wook Hur
Journal:  J Biol Chem       Date:  2008-09-18       Impact factor: 5.157

5.  Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.

Authors:  L Cheng; Z Zhou; A Flesken-Nikitin; I A Toshkov; W Wang; J Camps; T Ried; A Y Nikitin
Journal:  Oncogene       Date:  2010-08-02       Impact factor: 9.867

6.  Conditional deletion of the retinoblastoma (Rb) gene in ovarian granulosa cells leads to premature ovarian failure.

Authors:  Claudia Andreu-Vieyra; Ruihong Chen; Martin M Matzuk
Journal:  Mol Endocrinol       Date:  2008-07-03

7.  Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon.

Authors:  Melanie H Kucherlapati; Kan Yang; Kunhua Fan; Mari Kuraguchi; Dmitriy Sonkin; Andrew Rosulek; Martin Lipkin; Roderick T Bronson; Bruce J Aronow; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-01       Impact factor: 11.205

8.  Inactivating all three rb family pocket proteins is insufficient to initiate cervical cancer.

Authors:  Myeong-Kyun Shin; Julien Sage; Paul F Lambert
Journal:  Cancer Res       Date:  2012-08-31       Impact factor: 12.701

9.  Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer.

Authors:  Huda A Eltahir; Ahmed M Elhassan; Muntaser E Ibrahim
Journal:  Mol Med Rep       Date:  2012-06-11       Impact factor: 2.952

Review 10.  Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.

Authors:  David Frescas; Michele Pagano
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.